Avacta ready to ride a wave of product success

Posted on by admin

DIAGNOSTICS specialist Avacta said it is on the cusp of commercial success despite delays in launching a key veterinary product.

Chief executive Alastair Smith said the Wetherby-based company is now in its best-ever position, adding the imminent launch of its AX-1 animal diagnostics device should boost momentum.

The company, spun out of the University of Leeds, yesterday posted a 72 per cent surge in revenues to £1.7m for the six months to the end of January.

Avacta said sales of its flagship Optim device are ahead of target, with 13 units shipped in its first half. Optim is designed to speed up and reduce the cost of drug development. It claims to deliver vital information tens times faster than other approaches using much smaller samples

The devices sell for £92,500 each – Avacta earns £55,000 of this, with distributors taking the rest. It is targeting 25 Optim sales this year. Dr Smith said brokers expect the company to break even in the next year or two.

Finance director Tim Sykes said: “There’s substantial progress towards that kind of position and it’s very high on our agenda.”

Dr Smith added: “We are in a very good position with the core business moving towards profitability. There’s a lot more in the locker to come. We’re probably in the best position we’ve ever been in.”

Avacta ended January with £5.8m of cash – enough for three years.

Yorkshire Post 26th April 2012

http://www.yorkshirepost.co.uk/business/business-news/avacta-ready-to-ride-a-wave-of-product-success-1-4485159